Chikungunya Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Valneva, Moderna, Themis Bioscience, FIT Biotech, Bharat Biotech, Emergex, Indian Immunologicals, Auro Vaccines

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Chikungunya therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

"Chikungunya Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Chikungunya Therapeutics Market.

The report provides a detailed description of the Chikungunya drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Get a Detailed Overview of the Chikungunya Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/chikungunya-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Chikungunya Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Chikungunya therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Chikungunya treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Chikungunya drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Chikungunya treatment market.

Learn More about the Clinical and Commercial Development Activities in the Chikungunya Therapeutics Domain @
https://www.delveinsight.com/report-store/chikungunya-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Chikungunya Therapeutics Analysis
There are approx. 10+ key companies developing therapies for Chikungunya virus infections. Currently, Valneva is leading the therapeutics market with its Chikungunya virus infections drug candidates in the most advanced stage of clinical development.

Chikungunya Companies in the Therapeutics Market Include:
• Valneva
• Moderna Therapeutics
• Themis Bioscience
• FIT Biotech
• Bharat Biotech
• Emergex Vaccines
• Emergent BioSolutions
• Indian Immunologicals Ltd.
• Auro Vaccines
• Riboscience
And Many Others

Emerging and Marketed Chikungunya Therapies Covered in the Report Include:
• VLA1553: Valneva
VLA1553 is the chikungunya vaccine candidate that targets long-term protection following the administration of a single dose. Valneva reported positive topline results from a Phase 3 pivotal trial in August 2021. The trial, involving 4,115 adults, aged 18 years and above, across 44 sites in the U.S., met its primary endpoint inducing protective CHIKV neutralizing antibody titers in 98.5% of participants 28 days after receiving a single shot. VLA1553 was also generally well tolerated among the 3,082 subjects evaluated for safety. VLA1553 has received Fast Track and Breakthrough Therapy designation from the FDA and PRIME designation from the EMA

Get an in-depth Assessment of the Emerging Therapies and Chikungunya Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/chikungunya-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

The Report Covers the Emerging Chikungunya Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates

Route of Administration
Chikungunya virus infections pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical.

Molecule Type
Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy

Request for Sample PDF to Understand More About the Chikungunya Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/chikungunya-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content
1. Report Introduction
2. Executive Summary
3. Chikungunya Current Treatment Patterns
4. Chikungunya - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Chikungunya Late-Stage Products (Phase-III)
7. Chikungunya Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Chikungunya Discontinued Products
13. Chikungunya Product Profiles
14. Chikungunya Companies
15. Chikungunya Drugs
16. Dormant and Discontinued Products
17. Chikungunya Unmet Needs
18. Chikungunya Future Perspectives
19. Chikungunya Analyst Review
20. Appendix
21. Report Methodology

Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/chikungunya-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research

Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices

Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology

Other Trending Healthcare Reports by DelveInsight
Acute Ocular Pain Market
https://www.delveinsight.com/report-store/acute-ocular-pain-market

Acute On Chronic Liver Failure (ACLF) Market
https://www.delveinsight.com/report-store/acute-on-chronic-liver-failure-aclf-market

Antibody-Mediated Graft Rejection Market
https://www.delveinsight.com/report-store/antibody-mediated-graft-rejection-market

Bacterial (Pyogenic) Meningitis Market
https://www.delveinsight.com/report-store/bacterial-pyogenic-meningitis-market

Bevacizumab Biosimilars
https://www.delveinsight.com/report-store/bevacizumab-biosimilars-insight

Bronchial Neoplasm Market
https://www.delveinsight.com/report-store/bronchial-neoplasm-market

Calcinosis Cutis Market
https://www.delveinsight.com/report-store/calcinosis-cutis-market

Cardiovascular Calcification Market
https://www.delveinsight.com/report-store/cardiovascular-calcification-market

Dermal Regeneration Matrix Market
https://www.delveinsight.com/report-store/dermal-regeneration-matrix-market

Epstein Barr virus (EBV) Market
https://www.delveinsight.com/report-store/epstein-barr-virus-ebv-market

Glabellar Frown Lines Market
https://www.delveinsight.com/report-store/glabellar-frown-lines-market

Goitre Market
https://www.delveinsight.com/report-store/goitre-market

Hereditary Deafness Medical Device Market
https://www.delveinsight.com/report-store/hereditary-deafness-medical-devices-market

ICOS-Next Generation Immunotherapy Market
https://www.delveinsight.com/report-store/icos-next-generation-immunotherapy-competitive-landscape

Metrorrhagia Market
https://www.delveinsight.com/report-store/metrorrhagia-market

Nephrosclerosis Market
https://www.delveinsight.com/report-store/nephrosclerosis-market

Parkinson's Disease Related Dementia Market
https://www.delveinsight.com/report-store/parkinsons-disease-related-dementia-market

Peripherally Inserted Central Catheter (PICC) Devices Market
https://www.delveinsight.com/report-store/peripherally-inserted-central-catheter-picc-devices-market

Severe Toxicities in Lymphoma Market
https://www.delveinsight.com/report-store/severe-toxicities-in-lymphoma

Single Ventricle Heart Disease Market
https://www.delveinsight.com/report-store/single-ventricle-heart-disease-market

Small Fiber Neuropathy Market
https://www.delveinsight.com/report-store/small-fiber-neuropathy-market

Stuttering Market
https://www.delveinsight.com/report-store/stuttering-market

Venous Stenosis Market
https://www.delveinsight.com/report-store/venous-stenosis-market

Hyperopia Market
https://www.delveinsight.com/report-store/hyperopia-market

Microvascular Angina Market
https://www.delveinsight.com/report-store/microvascular-angina-market

Progressive Familial Intrahepatic Cholestasis Market
https://www.delveinsight.com/report-store/progressive-familial-intrahepatic-cholestasis-pfic-market

CRISPR Therapies Pipeline Insight
https://www.delveinsight.com/report-store/crispr-therapies-pipeline-insight

Endometrial Hyperplasia Market
https://www.delveinsight.com/report-store/endometrial-hyperplasia-market

Adenoid Cystic Carcinoma Market
https://www.delveinsight.com/report-store/adenoid-cystic-carcinom-market

Chronic Pain Associated with Painful Diabetic Neuropathy Market
https://www.delveinsight.com/report-store/chronic-pain-associated-with-painful-diabetic-neuropathy-market

Contact Dermatitis Market
https://www.delveinsight.com/report-store/contact-dermatitis-market

Dermal Mycosis Market
https://www.delveinsight.com/report-store/dermal-mycosis-market

High-Grade Glioma Market
https://www.delveinsight.com/report-store/high-grade-glioma-hgg-market

Lymphatic Malformations Market
https://www.delveinsight.com/report-store/lymphatic-malformations-market

Nocturnal Enuresis Market
https://www.delveinsight.com/report-store/nocturnal-enuresis-market

Ulcer Haemorrhage Market
https://www.delveinsight.com/report-store/ulcer-haemorrhage-market

Adult-onset Still Disease Market
https://www.delveinsight.com/report-store/adult-onset-still-disease-market

Alcohol Use Disorder (AUD) Market
https://www.delveinsight.com/report-store/alcohol-use-disorder-market

Cell And Gene Therapy For Multiple Myeloma Market
https://www.delveinsight.com/report-store/cell-and-gene-therapy-for-multiple-myeloma-market

Chronic Pancreatitis (CP) Market
https://www.delveinsight.com/report-store/chronic-pancreatitis-market

Cough in Idiopathic Pulmonary Fibrosis (IPF) Market
https://www.delveinsight.com/report-store/cough-in-idiopathic-pulmonary-fibrosis-ipf-market

End-Stage Coronary Artery Disease Market
https://www.delveinsight.com/report-store/end-stage-coronary-artery-disease-market

Frontotemporal Dementia Market
https://www.delveinsight.com/report-store/frontotemporal-dementia-market

Cell and Gene Therapies in Rare Disorders Market
https://www.delveinsight.com/report-store/gene-and-cell-therapies-in-rare-disorder-market

Glycogen Storage Disease Market
https://www.delveinsight.com/report-store/glycogen-storage-disease-market

Maple Syrup Urine Disease Market
https://www.delveinsight.com/report-store/maple-syrup-urine-disease-market

MELAS Syndrome Market
https://www.delveinsight.com/report-store/melas-syndrome-market

Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.